The Wall Street Journal published an article explaining the benefits of pharmacogenomic testing. Pharmacogenomics identifies which inherited genetic variations a person has and predicts how an individual will — or will not — respond to specific medications.
Because everyone responds to drugs di...
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, announced today that it will move its corporate office and clinical laboratory to the Highlight Center in northeast Minneapolis in early 2016. The new location will expand OneOme’s operations with a high-throughput clinical laborato...
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently announced that it appointed Paul Owen as its Chief Operating Officer.
Troy Kopischke, CEO, stated: “Owen’s experience and expertise in pharmacogenomics are incredible assets for OneOme. His leadership will drive OneOme...
MINNEAPOLIS, Minnesota—OneOme, LLC, a pharmacogenomics company, recently analyzed genetic data from the first two patients using the PGxExpress product developed in collaboration with Mayo Clinic. Both analyses were delivered successfully in the form of comprehensive reports to the patients throug...
